Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

aprevo® posterior/transforaminal lumbar interbody fusion device

K-Number: K250987 · 2025-06-30

Decision Date2025-06-30
Product CodeMAX
Advisory CommitteeOR
DecisionSubstantially Equivalent

Device Summary

aprevo® posterior/transforaminal lumbar interbody fusion device is a medical device manufactured by Carlsmed, Inc.. It received FDA 510(k) clearance on 2025-06-30 under approval number K250987. The device is classified under product code MAX. It was reviewed by the OR advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the aprevo® posterior/transforaminal lumbar interbody fusion device?

aprevo® posterior/transforaminal lumbar interbody fusion device is a medical device that received FDA 510(k) clearance on 2025-06-30. It is manufactured by Carlsmed, Inc.. The 510(k) number is K250987.

When was aprevo® posterior/transforaminal lumbar interbody fusion device approved by the FDA?

aprevo® posterior/transforaminal lumbar interbody fusion device received FDA 510(k) clearance on 2025-06-30, under approval number K250987.

What company makes aprevo® posterior/transforaminal lumbar interbody fusion device?

aprevo® posterior/transforaminal lumbar interbody fusion device is manufactured by Carlsmed, Inc..

What is the FDA product code for aprevo® posterior/transforaminal lumbar interbody fusion device?

The FDA product code for aprevo® posterior/transforaminal lumbar interbody fusion device is MAX.

Related Clinical Trials

Related PubMed Literature

Other Devices by Carlsmed, Inc.

View all 21 devices →

Related Devices (Code: MAX)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.